Key supporting research from 2024-2025 includes a July 2024 paper in Inflammopharmacology (PMID: 38980576) linking BPC-157 to stress response mechanisms, a January 2025 HSS Journal systematic review on neuromuscular applications (PMID: 40756949), and a 2025 Journal of Neuropsychiatry and Clinical Neurosciences perspectives paper positioning BPC-157 as an emerging therapeutic for CNS disorders
Steinberg HO, Tarshoby M, Monestel R, et al
But public perception has really turned against data centers and local pushback is causing planned data centers to be canceled or delayed
- no Nurse Initiated interventions administered
For general weight loss, GLP-1 and GIP/GLP-1 medications such as semaglutide and tirzepatide are more effective
Some studies show that one year after stopping Ozempic, patients gained back about two-thirds of the weight they originally lost